gimli
AGARWALEYE stock AI analysis

AGARWALEYE Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

DR AGARWALS HEALTH CARE L is a small-cap stock in Healthcare. This Gimli page shows the latest available AGARWALEYE price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Price
₹550.70
1W return
+6.65%
1M return
+18.23%
3M return
+8.73%
6M return
+22.35%
1Y return
+5.20%
Market cap
₹17,456.25 cr
PE
84.99
PB
7.81
ROE
+10.15%
ROCE
+12.71%
RSI
72.77
Turnover
₹4.40 cr

Why it can matter in screens

Quick Answers

What is the latest AGARWALEYE stock price?

The latest stored price for AGARWALEYE is Rs 550.70 as of 2026-11-16.

Is AGARWALEYE above its 50DMA and 200DMA?

AGARWALEYE is above 50DMA, above 200DMA. The latest 50DMA is 498.88 and the latest 200DMA is 472.13.

What are AGARWALEYE PE, ROE and ROCE?

AGARWALEYE has PE 84.99, ROE +10.15%, and ROCE +12.71% in Gimli's latest available snapshot.

How has AGARWALEYE performed recently?

AGARWALEYE has returned +18.23% over 1 month, +8.73% over 3 months, and +5.20% over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

PeriodRevenueEBITDAPATEPS
2026-09-30655.46 cr185.56 cr56.80 cr1.65
2026-06-30614.02 cr176.82 cr55.00 cr1.43
2026-03-31564.11 cr175.38 cr50.00 cr1.25
2025-12-31529.86 cr154.64 cr43.60 cr1.07
2025-09-30315.79 cr144.07 cr36.50 cr1.07
2025-06-30487.42 cr141.25 cr30.05 cr0.95
2025-03-31460.22 cr143.92 cr32.57 cr1.04
2024-12-31430.72 cr127.52 cr22.34 cr0.71

Annual income statement

YearRevenueEBITDAPATEPS
2026-03-312,080.08 cr615.34 cr133.19 cr4.21
2025-03-311,711.00 cr499.38 cr83.46 cr2.80
2024-03-311,327.67 cr406.56 cr83.06 cr2.63
2023-03-311,016.48 cr283.86 cr94.10 cr2.98
2022-03-31371.96 cr196.12 cr-1.47 cr1.19

Balance sheet

PeriodAssetsCashDebtEquity
2026-03-313,941.75 cr90.55 cr1,066.20 cr2,119.70 cr
2025-03-313,671.57 cr103.61 cr960.91 cr1,926.82 cr
2024-03-312,752.82 cr111.75 cr966.44 cr1,379.51 cr
2023-03-311,825.17 cr126.98 cr857.35 cr659.07 cr
2022-03-311,026.13 cr99.62 cr618.56 cr233.82 cr

Cash flow

PeriodOCFFCFCash change
2026-03-31518.99 cr58.41 crn/a
2025-03-31357.13 cr36.23 crn/a
2024-03-31346.00 cr113.67 crn/a
2023-03-31233.11 cr75.31 crn/a
2022-03-31164.33 cr93.75 crn/a

Shareholding Trend

PeriodPromoterFII/FPIDIIMFRetailPledge
2026-09-30+32.33%+49.56%+15.87%+14.18%+2.24%+0.00%
2026-06-30+32.34%+57.96%+7.72%+6.02%+1.98%+0.00%
2026-03-31+32.36%+57.94%+7.83%+5.87%+1.87%+0.00%
2025-12-31+32.39%+58.06%+7.78%+5.77%+1.77%+0.00%
2025-09-30+32.42%+58.13%+7.92%+5.85%+1.52%+0.00%
2025-06-30+32.42%+59.26%+6.44%+4.91%+1.88%+0.00%
2025-03-31+32.45%+60.62%+5.21%+3.84%+1.72%+0.00%
2025-02-03+32.45%+56.97%+5.10%+3.18%+5.49%+0.00%

Industry Peers

SymbolNameMcapPEROE1Y
SUNPHARMASUN PHARMACEUTICAL IND L448,075.81 cr40.781879+14.03%+6.28%
DIVISLABDIVI S LABORATORIES LTD294,139.21 cr87.463339+21.13%+70.16%
TORNTPHARMTORRENT PHARMACEUTICALS L178,438.17 cr85.011038+16.67%+22.43%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L126,113.56 cr53.952325+24.95%+18.20%
LAURUSLABSLAURUS LABS LIMITED119,848.17 cr89.960566+26.71%+122.22%
ZYDUSLIFEZYDUS LIFESCIENCES LTD118,902.46 cr27.636309+15.44%+26.21%
DRREDDYDR. REDDY S LABORATORIES114,723.24 cr41.579949+7.80%+10.59%
CIPLACIPLA LTD112,647.78 cr39.472630+8.80%-8.98%

Try these prompts

Related screen ideas

Data snapshot: 2026-11-16. Not investment advice.